Literature DB >> 22677186

CD22 and Siglec-G in B cell function and tolerance.

Jonathan C Poe1, Thomas F Tedder.   

Abstract

The immune system has evolved into two main arms: the primitive innate arm that is the first line of defense but relatively short-lived and broad acting; and the advanced adaptive arm that generates immunological memory, allowing rapid, specific recall responses. T cell-independent type-2 (TI-2) antigens (Ags) invoke innate immune responses. However, due to its 'at the ready' nature, how the innate arm of the immune system maintains tolerance to potentially abundant host TI-2 Ags remains elusive. Therefore, it is important to define the mechanisms that establish innate immune tolerance. This review highlights recent insights into B cell tolerance to theoretical self TI-2 Ags, and examines how the B cell-restricted sialic acid binding Ig-like lectins (Siglecs), CD22 and Siglec-G, might contribute to this process.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22677186      PMCID: PMC3407281          DOI: 10.1016/j.it.2012.04.010

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  76 in total

1.  Identification of anergic B cells within a wild-type repertoire.

Authors:  Kevin T Merrell; Robert J Benschop; Stephen B Gauld; Katja Aviszus; Debora Decote-Ricardo; Lawrence J Wysocki; John C Cambier
Journal:  Immunity       Date:  2006-12       Impact factor: 31.745

Review 2.  BAFF and the plasticity of peripheral B cell tolerance.

Authors:  Jason E Stadanlick; Michael P Cancro
Journal:  Curr Opin Immunol       Date:  2008-05-02       Impact factor: 7.486

3.  CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo.

Authors:  Karen M Haas; Suman Sen; Isaac G Sanford; Ann S Miller; Jonathan C Poe; Thomas F Tedder
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

Review 4.  Siglecs and their roles in the immune system.

Authors:  Paul R Crocker; James C Paulson; Ajit Varki
Journal:  Nat Rev Immunol       Date:  2007-04       Impact factor: 53.106

Review 5.  CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.

Authors:  Lars Nitschke
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

6.  Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population.

Authors:  Anja Hoffmann; Sheena Kerr; Julia Jellusova; Jiquan Zhang; Florian Weisel; Ute Wellmann; Thomas H Winkler; Burkhard Kneitz; Paul R Crocker; Lars Nitschke
Journal:  Nat Immunol       Date:  2007-06-17       Impact factor: 25.606

7.  The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.

Authors:  Koichi Yanaba; Jean-David Bouaziz; Takashi Matsushita; Takeshi Tsubata; Thomas F Tedder
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

8.  CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.

Authors:  Guo-Yun Chen; Jie Tang; Pan Zheng; Yang Liu
Journal:  Science       Date:  2009-03-05       Impact factor: 47.728

9.  Endocytic sequestration of the B cell antigen receptor and toll-like receptor 9 in anergic cells.

Authors:  Shannon K O'Neill; Margaret L Veselits; Miao Zhang; Christine Labno; Yanxia Cao; Alison Finnegan; Melissa Uccellini; Maria-Luisa Alegre; John C Cambier; Marcus R Clark
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-30       Impact factor: 11.205

10.  Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.

Authors:  Aaron F Carlin; Satoshi Uchiyama; Yung-Chi Chang; Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Blood       Date:  2009-02-04       Impact factor: 22.113

View more
  25 in total

1.  Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.

Authors:  Fabian Pfrengle; Matthew S Macauley; Norihito Kawasaki; James C Paulson
Journal:  J Immunol       Date:  2013-07-08       Impact factor: 5.422

2.  SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders.

Authors:  Giorgia Simonetti; Maria Teresa Sabrina Bertilaccio; Tania Veliz Rodriguez; Benedetta Apollonio; Antonis Dagklis; Martina Rocchi; Anna Innocenzi; Stefano Casola; Thomas H Winkler; Lars Nitschke; Maurilio Ponzoni; Federico Caligaris-Cappio; Paolo Ghia
Journal:  Haematologica       Date:  2014-05-23       Impact factor: 9.941

Review 3.  Therapeutic Potential of B-1a Cells in COVID-19.

Authors:  Monowar Aziz; Max Brenner; Ping Wang
Journal:  Shock       Date:  2020-11       Impact factor: 3.454

4.  CD22ΔE12 as a molecular target for corrective repair using RNA trans-splicing: anti-leukemic activity of a rationally designed RNA trans-splicing molecule.

Authors:  Fatih M Uckun; Sanjive Qazi; Hong Ma; Gregory H Reaman; Lloyd G Mitchell
Journal:  Integr Biol (Camb)       Date:  2015-02       Impact factor: 2.192

5.  Siglecs induce tolerance to cell surface antigens by BIM-dependent deletion of the antigen-reactive B cells.

Authors:  Matthew S Macauley; James C Paulson
Journal:  J Immunol       Date:  2014-09-24       Impact factor: 5.422

Review 6.  Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity.

Authors:  Guo-Yun Chen; Nicholas K Brown; Pan Zheng; Yang Liu
Journal:  Glycobiology       Date:  2014-07-04       Impact factor: 4.313

Review 7.  The long elusive IgM Fc receptor, FcμR.

Authors:  Hiromi Kubagawa; Satoshi Oka; Yoshiki Kubagawa; Ikuko Torii; Eiji Takayama; Dong-Won Kang; Dewitt Jones; Naonori Nishida; Toshio Miyawaki; Luigi F Bertoli; Sheila K Sanders; Kazuhito Honjo
Journal:  J Clin Immunol       Date:  2014-05-03       Impact factor: 8.317

Review 8.  Siglec-mediated regulation of immune cell function in disease.

Authors:  Matthew S Macauley; Paul R Crocker; James C Paulson
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

9.  A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.

Authors:  Anne B Satterthwaite; Wei Luo; Jessica Mayeux; Toni Gutierrez; Lisa Russell; Andrew Getahun; Jennifer Müller; Thomas Tedder; Jane Parnes; Robert Rickert; Lars Nitschke; John Cambier; Lee Ann Garrett-Sinha
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

10.  CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.

Authors:  Karen M Haas; Kristen L Johnson; James P Phipps; Cardinal Do
Journal:  J Immunol       Date:  2018-01-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.